Acorah Software Products - Accounts Production 14.5.501 false true false true No description of principal activity 23 October 2022 31 October 2023 31 October 2023 14436972 Mr Waseem Khan iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14436972 2022-10-22 14436972 2023-10-31 14436972 2022-10-23 2023-10-31 14436972 frs-core:CurrentFinancialInstruments 2023-10-31 14436972 frs-bus:PrivateLimitedCompanyLtd 2022-10-23 2023-10-31 14436972 frs-bus:FilletedAccounts 2022-10-23 2023-10-31 14436972 frs-bus:Micro-entities 2022-10-23 2023-10-31 14436972 frs-bus:AuditExempt-NoAccountantsReport 2022-10-23 2023-10-31 14436972 frs-bus:Director1 2022-10-23 2023-10-31
Registered number: 14436972
WK Pharma Ltd
Unaudited Financial Statements
For the Period 23 October 2022 to 31 October 2023
AWR Accountants Limited
Balance Sheet
Registered number: 14436972
31 October 2023
£
Fixed assets 877
Current assets 24,114
Prepayments and accrued income 150
Creditors: Amounts Falling Due Within One Year (25,041 )
NET CURRENT LIABILITIES (777 )
TOTAL ASSETS LESS CURRENT LIABILITIES 100
NET ASSETS 100
CAPITAL AND RESERVES 100

Notes

1. General Information
WK Pharma Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14436972 . The registered office is 26 Craddock Road, Smethwick, B67 7AS.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 2
2
For the period ending 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Mr Waseem Khan
Director
29/03/2024